Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Paricalcitol market in this environment.
In terms of revenue, this research report indicated that the global Paricalcitol market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Paricalcitol industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The ChemWerth Inc aims at producing XX Paricalcitol in 2020, with XX % production to take place in global market, ALP Pharm Beijing Co., Ltd accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Paricalcitol Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Paricalcitol Market?
ChemWerth Inc
ALP Pharm Beijing Co., Ltd
Chongqing Huapont Pharmaceutical Co. Ltd
DISHMAN NETHERLANDS B.V.
Haoyuan Chemexpress Co.Ltd
Neuland Laboratories Inc
Rochem International, Inc
Teva Pharmaceutical Industries Ltd
...
Major Type of Paricalcitol Covered in XYZResearch report:
High Purity
Low Purity
Application Segments Covered in XYZResearch Market
Injection Product
Capsule Product
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Paricalcitol Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 High Purity -Product Introduction and Major Manufacturers
1.1.2 Low Purity -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Paricalcitol Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Paricalcitol Market
3.1.1 Top Companies leading Paricalcitol Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Paricalcitol Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Paricalcitol Market
3.2.1 Top Companies leading Paricalcitol Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Paricalcitol Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Paricalcitol Market
3.3.1 Top Companies leading Paricalcitol Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Paricalcitol Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Paricalcitol Market
3.4.1 Top Companies leading Paricalcitol Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Paricalcitol Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Paricalcitol Market
3.5.1 Top Companies leading Paricalcitol Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Paricalcitol Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Paricalcitol Market
3.6.1 Top Companies leading Paricalcitol Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Paricalcitol Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Paricalcitol Market
3.7.1 Top Companies leading Paricalcitol Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Paricalcitol Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Paricalcitol Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Paricalcitol Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Paricalcitol Sales and Growth Rate (2021-2026)
5.2 Global Paricalcitol Sales Value and Growth Rate (2021-2026)
6 Paricalcitol Competitive Analysis
6.1 ChemWerth Inc
6.1.1 ChemWerth Inc Company Profiles
6.1.2 ChemWerth Inc Product Introduction
6.1.3 ChemWerth Inc Paricalcitol Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 ALP Pharm Beijing Co., Ltd
6.2.1 ALP Pharm Beijing Co., Ltd Company Profiles
6.2.2 ALP Pharm Beijing Co., Ltd Product Introduction
6.2.3 ALP Pharm Beijing Co., Ltd Paricalcitol Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Chongqing Huapont Pharmaceutical Co. Ltd
6.3.1 Chongqing Huapont Pharmaceutical Co. Ltd Company Profiles
6.3.2 Chongqing Huapont Pharmaceutical Co. Ltd Product Introduction
6.3.3 Chongqing Huapont Pharmaceutical Co. Ltd Paricalcitol Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 DISHMAN NETHERLANDS B.V.
6.4.1 DISHMAN NETHERLANDS B.V. Company Profiles
6.4.2 DISHMAN NETHERLANDS B.V. Product Introduction
6.4.3 DISHMAN NETHERLANDS B.V. Paricalcitol Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Haoyuan Chemexpress Co.Ltd
6.5.1 Haoyuan Chemexpress Co.Ltd Company Profiles
6.5.2 Haoyuan Chemexpress Co.Ltd Product Introduction
6.5.3 Haoyuan Chemexpress Co.Ltd Paricalcitol Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Neuland Laboratories Inc
6.6.1 Neuland Laboratories Inc Company Profiles
6.6.2 Neuland Laboratories Inc Product Introduction
6.6.3 Neuland Laboratories Inc Paricalcitol Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Rochem International, Inc
6.7.1 Rochem International, Inc Company Profiles
6.7.2 Rochem International, Inc Product Introduction
6.7.3 Rochem International, Inc Paricalcitol Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Teva Pharmaceutical Industries Ltd
6.8.1 Teva Pharmaceutical Industries Ltd Company Profiles
6.8.2 Teva Pharmaceutical Industries Ltd Product Introduction
6.8.3 Teva Pharmaceutical Industries Ltd Paricalcitol Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
7 Conclusion
The research team projects that the Paricalcitol market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user unde...
The research team projects that the PARICALCITOL (10 MG)F0E3030.997MG/MG(AI) CAS 131918-61-1 market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime o...
The research team projects that the Paricalcitol market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user ...
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, ...
Summary
As the world continues to deal with COVID-19, economies are moving into recession, official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countri...
According to XYZResearch study, over the next five years the Paricalcitolmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key...
The Paricalcitol Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Paricalcitol Market. With the use of historic data from (period), the Paricalcitol Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered i...
In this report, the global Paricalcitol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (MT), revenue (Mil...
In this report, the United States Paricalcitol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
...
In this report, the EMEA Paricalcitol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), r...